Skip to product information
1 of 1

SJ988497 [CAS 2595365-41-4]

SJ988497 [CAS 2595365-41-4]

Size

SKU:QM-0150690-01

£501.98 GBP
Sale Sold out
Quantity

Request quote or documents

View full details
  • Description

    SJ988497 is a PROTAC JAK2 degrader. SJ988497 potently inhibits CRLF2-rearranged (CRLF2r) cell proliferation and degrades the CRBN neosubstrate GSPT1. SJ988497 consists of a Ruxolitinib derivative, linker, and CRBN ligand Pomalidomide. SJ988497 can be used in the research of acute lymphoblastic leukemia (ALL).

  • CAS Number

    [2595365-41-4]

  • Molecular Formula

    C36H36N10O5

  • Molecular Weight

    688.74

  • Smiles

    CCCN1C=C(C=N1)C2=C3C=CNC3=NC(NC4=CC=C(C=C4)C(NCCCCNC5=C6C(N(C(C6=CC=C5)=O)C7CCC(NC7=O)=O)=O)=O)=N2

  • Target

    JAK; PROTACs

  • Isoform

    JAK2

  • Purity

    99.03

  • Solubility

    DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 80°C)

  • Storage Conditions

    -20°C, 3 years; 4°C, 2 years (Powder)

  • Shipping Conditions

    Room Temperature

Your cart
Variant Variant total Quantity Price Variant total
1 mgQM-0150690-01
1 mgQM-0150690-01
Regular price
£334.80
Sale price
£501.98/ea
£0.00
Regular price
£334.80
Sale price
£501.98/ea
£0.00
5 mgQM-0150690-02
5 mgQM-0150690-02
Regular price
£743.40
Sale price
£1,053.59/ea
£0.00
Regular price
£743.40
Sale price
£1,053.59/ea
£0.00
10 mgQM-0150690-03
10 mgQM-0150690-03
Regular price
£1,189.80
Sale price
£1,656.23/ea
£0.00
Regular price
£1,189.80
Sale price
£1,656.23/ea
£0.00
25 mgQM-0150690-04
25 mgQM-0150690-04
Regular price
£2,380.50
Sale price
£3,263.68/ea
£0.00
Regular price
£2,380.50
Sale price
£3,263.68/ea
£0.00
50 mgQM-0150690-05
50 mgQM-0150690-05
Regular price
£3,807.90
Sale price
£5,190.66/ea
£0.00
Regular price
£3,807.90
Sale price
£5,190.66/ea
£0.00

View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

SJ988497 [CAS 2595365-41-4]

SJ988497 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.